Letter in response to: Identifying risk in the use of tumor markers to improve patient safety

Clin Chem Lab Med. 2016 Dec 1;54(12):e383-e384. doi: 10.1515/cclm-2016-0335.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Biomarkers, Tumor*
  • Humans
  • Patient Safety*
  • Risk

Substances

  • Biomarkers, Tumor